3 unknown, 2 completed, 2 recruiting, 1 withdrawn. 4 Not applicable, 3 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 4 | Unknown 3, Completed 1 |
| Phase 2 | 3 | Recruiting 2, Withdrawn 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow The placebo group: new trials by email Literature Review of The placebo group trials Research Report on The placebo group
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intra-arterial Methylprednisolone After Endovascular Thrombectomy The methylprednisolone sodium succinate group, The placebo group - Ischemia Stroke, Thrombectomy | Phase 2 | Recruiting | Tang-Du Hospital | 210 | 2026-03-31 | 2026-04-08 |
| A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic Dermatitis The high-dose group of ZL-82 tablets, The low-dose group of ZL-82 tablets, The placebo group - Atopic Dermatitis | Phase 2 | Recruiting | Chengdu Zenitar Biomedical Technology Co., Ltd | 111 | 2026-02-03 | 2026-02-04 |
| The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy The intravenous ferritin group, The placebo group - Pancreaticojuodenectomy | Not applicable | Unknown | Seoul St. Mary's Hospital | 106 | 2024-07-01 | 2024-06-04 |
| Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery Mosapride, Placebo - Colorectal Cancer, Bowel Ileus | Not applicable | Unknown | Mahidol University | 44 | 2021-07-01 | 2021-09-02 |
| Tolerability & Pharmacokinetics of Ginkgolide B Injection: Single- and Multiple-Ascending Doses in Healthy Subjects The 10mg dose group, The 20mg dose group, The 30mg dose group - Healthy Volunteers | Phase 1 | Completed | West China Second University Hospital | 36 | 2021-07-01 | 2026-03-09 |
| An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Protect Against COVID-19 in Adults Over Aged 18 Years-old and Older Adjuvanted SARS-CoV-2 Subunit vaccine (aCoV2), Comparator - Influenza | Phase 2 / Phase 3 | Withdrawn | Seqirus | 2020-12-15 | 2021-03-23 | |
| An fMRI Study of Jianpi Yishen Huatan Granules for Cognitive Impairment After Acute Cerebral Infarction Jianpi Yishen Huatan Granules, the placebo - Cognitive Impairment | Not applicable | Unknown | Dongfang Hospital Beijing University of Chinese Medicine | 40 | 2016-12-01 | 2019-02-26 |
| The Study of Jian Pi Yi Shen Hua Tan Granules in Cognitive Impairment After Acute Cerebral Infarction Jian Pi Yi Shen Hua Tan Granules, the placebo group - Cognitive Impairment | Not applicable | Completed | Dongfang Hospital Beijing University of Chinese Medicine | 300 | 2016-03-09 | 2019-07-19 |
Cognitive Dysfunction (2) · Anemia, Iron-Deficiency (1) · Colorectal Neoplasms (1) · Dermatitis, Atopic (1) · Ileus (1) · Influenza, Human (1) · Ischemic Stroke (1)
Dongfang Hospital Beijing University of Chinese Medicine (2) · Chengdu Zenitar Biomedical Technology Co., Ltd (1) · Mahidol University (1) · Seoul St. Mary's Hospital (1) · Seqirus (1) · Tang-Du Hospital (1) · West China Second University Hospital (1)
China (5) · Thailand (1)
Bensita Saengsawang, MD (1) · Chairat Supsamutchai, MD (1) · Jakrapan Jirasiritham, MD (1) · Qin Yu (1) · Tharin Thampongsa, MD (1) · Yan Qu, MD (1) · Yunling Zhang (1) · Yunling Zhang, PhD,MD (1)